Lexaria Bioscience Corp. (LEXX)
0.668
+0.02
(+3.31%)
USD |
NASDAQ |
Jun 09, 16:00
0.6878
+0.02
(+2.96%)
After-Hours: 20:00
Lexaria Bioscience Total Assets (Quarterly) : 6.487M for Feb. 28, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pharmagreen Biotech, Inc. | 0.5921M |
| Target Group, Inc. (Canada) | 6.076M |
| InMed Pharmaceuticals, Inc. | 9.134M |
| NervGen Pharma Corp. | 14.88M |
| Milestone Pharmaceuticals, Inc. | 193.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.277M |
| Shareholders Equity (Quarterly) | 6.602M |
| Debt to Equity Ratio | 0.0143 |
| Current Ratio | 26.88 |
| Net Debt Paydown Yield | 0.04% |